03.22.21 -- Scaling Up A Successful Technology Transfer

Optimal cell line development is crucial for successfully navigating clinical trials and diverse, challenging regulatory approval processes. Discover what you should know about cell line development to ensure a successful launch.

The standardization of biologics manufacturing processes has given product developers multiple viable options for producing monoclonal antibodies (mAbs), including building an in-house mAb production system or partnering with a contract biologics manufacturer. This article shares a success story for an early-stage technology transfer and the parameters to consider to stay ahead of your competitors.

Large-scale technology transfers often present significant technical and operational challenges. Manufacturing at scale requires adherence to established, scale-dependent process parameters and close examination of product characteristics and quality attributes. Learn the key considerations when preparing to move products from small-scale to large-scale production.

As the biopharma industry continues to integrate more digital solutions into the manufacturing space, we are also quickly adapting — with integrated systems, virtual user experiences, and technology initiatives. Through digital transformation, we are innovating how we connect while driving enhanced client experiences with efficiency and advanced mobility.